[Heparin treatment in peracute glomerulonephritis].
D000208:Acute Disease; D019867:Anti-Glomerular Basement Membrane Disease / Q000150:complications; D001796:Blood Protein Disorders / Q000150:complications; D002986:Clinical Trials as Topic; D003450:Cryoglobulins; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006463:Hemolytic-Uremic Syndrome / Q000150:complications; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D006973:Hypertension / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D010488:Polyarteritis Nodosa / Q000150:complications; D011693:Purpura / Q000150:complications
D003450:Cryoglobulins; D006493:Heparin
Heparintherapie bei perakuter Glomerulonephritis